Residon Indications/Uses

Risperidone is indicated in the treatment of patient groups with schizoprenia, including the first psychotic episode, acute schizophrenic episodes, chronic schizophrenia and other psychotic conditions where positive symptoms (such as hallucinations, delirium ideas, thought disorders, hostility, distrust) and/or negative symptoms (such as emotional bluntness, emotional and social withdrawal, speech difficulty) are instense. Risperidone also alleviates emotional disorders (such as depression, feeling of guilt, anxiety) that relate to schizophrenia.
Risperidone is also effective in maintaining clinical improvement during continuous treatment in patients who have showed response to the initial treatment.
Additionally, risperidone is indicated in the treatment of behavioral disorders in patients with dementia whose symptoms such as aggressiveness (verbal outbreaks-outbursts, physical violence) activity disorders (stimulation, agitation) or psychotic syndromes are intense.
Risperidone is also indicated as additional treatment in with mood stabilizers in the treatment of maniac episodes accompanied by bipolar disorders. These episodes are characterized by symptoms increased, extensive or irritable mood, excessive self-esteem, reduced need for sleep, suppressed speech, origin thoughts and difficulty in concentration or poor judgment including disruptive or aggressive behavior.
Risperidone is indicated in the treatment of developmental or other disorders of disruptive behavior in patients with mental function that is rated under the average or mental retirement, whose destructive behavior (i.e. aggressiveness, impulsiveness, self-injuring behaviors) is intense.